Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$90,703,947
+$40,695,745 QoQ
Shares Held
2,681,169
+45.9% QoQ
Ownership
4.51%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Dec 31, 2025CallValue
$656,002
CallShares
24,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. AGIO ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in AGIO
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $90,703,947 | 2,681,169 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $656,002 | 24,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $50,008,202 | 1,837,186 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,761,443 | 367,749 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,829,678 | 596,202 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,256,226 | 554,820 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $16,971,367 | 516,475 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,654,709 | 532,404 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $29,245,450 | 678,234 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,588,797 | 362,134 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,821,098 | 216,484 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,917,430 | 158,280 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,714,755 | 95,860 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,346,293 | 102,146 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,655,607 | 165,798 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,237,709 | 291,291 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,128,209 | 276,419 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $873,300 | 30,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $1,471,306 | 50,543 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,742,775 | 113,866 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $986,100 | 30,000 | Put | Defined | 2022-02-14 | |
| 2021-09-30 | $6,495,797 | 140,754 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,178,692 | 21,388 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,459,527 | 86,358 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,060,679 | 186,030 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,748,450 | 335,670 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,907,153 | 260,044 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,753,784 | 105,800 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $8,064,710 | 227,303 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||